

Please try another search
Blueprint Medicines Corporation is a global precision therapy company that is inventing medicines for people with cancer and blood disorders. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib) to patients in the United States and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer and other genomically defined cancers, and cancer immunotherapy. Its pipelines also include BLU-263 (KIT), AYVAKIT (avapritinib) (PDGFRA), BLU-701 (EGFR), BLU-945 (EGFR), BLU-451 (EGFR exon 20 insertions), BLU-222 (CDK2) and BLU-852 (MAP4K1). It is developing and commercializing avapritinib for the treatment of advanced SM, and developing avapritinib for the treatment of non-advanced SM. The Company is developing BLU-263, an investigational, orally available KIT inhibitor, for the treatment of non-advanced SM and other mast cell disorders.
Name | Age | Since | Title |
---|---|---|---|
Lonnel Coats | 57 | 2016 | Independent Director |
William C. Hahn | - | - | Member of Scientific Advisory Board |
Scott W. Lowe | - | - | Member of Scientific Advisory Board |
Brian J. Druker | 66 | - | Member of Scientific Advisory Board |
Lynn Seely | 63 | 2016 | Lead Independent Director |
Mark A. Goldberg | 68 | 2015 | Independent Director |
Habib J. Dable | 53 | 2022 | Director |
Daniella Beckman | 43 | 2021 | Independent Director |
Charles L. Sawyers | 63 | - | Member of Scientific Advisory Board |
Giulio F. Draetta | - | - | Member of Scientific Advisory Board |
Nicholas B. Lydon | 65 | 2011 | Member of Scientific Advisory Board & Independent Director |
Alexis A. Borisy | 51 | 2011 | Co-Founder & Director |
Jeffrey W. Albers | 52 | 2014 | Chairman |
Kathryn Haviland | 47 | 2016 | President, CEO & Director |
George Daniel Demetri | 66 | 2012 | Member of Scientific Advisory Board |
John Tsai | 56 | 2023 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review